FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997863586> ?p ?o ?g. }

• W2997863586 abstract "e13031 Background: The most important dose-limiting manifestation of cisplatin is renal tubular dysfunction and a cumulative impairment in renal function, as manifested by a decline in the glomerular filtration rate (GFR). There is a clinical need to predict the probability of cisplatin-induced nephrotoxicity (CIN), in order to support decisions about patient management and preventive measures. The aim of the present study was to develop risk prediction of CIN. Methods: Consecutive 197 patients with documented serum creatinine before at least 48 hours every cycle cisplatin-based chemotherapy were included the study. Demographic and medical data including age, performance status, tumor characteristics and comorbid diseases were collected from the medical charts. Renal function was evaluated for each cycle before treatment (day 0) and before next cycle (day 21) based on the Modification of Diet in Renal Disease (MDRD) formula. Cisplatin-induced nephrotoxicity (CIN) was defined as decrease of ≥ 25% in GFR compared to baseline GFR values. Results: The mean age of the study population was 54.5±9.6 years. Baseline MDRD levels had decreased of ≥ 25% in 58 (29.4%) patients accepted as CIN group, the rest of 139 patients of the study population accepted as a non-CIN group. There was no difference of age, gender, body mass index and smoking history between groups. In both group, the hypertension (p=0.81), diabetes mellitus (p=0.72), and cardiovascular disease (p=0.58) were seen equally. Types of concomitant therapy with cisplatin-based chemotherapy were similar between CIN and non-CIN groups. The applied radiologic examinations with contrast media was observed higher in CIN group than non-CIN group (P=0.01). In patients exposure the contrast media within one week before cisplatin administration, the risk of CIN was observed 2.56 (95%CI: 1.28-5.11) times higher than in patients not exposure to the contrast (p=0.009). Conclusions: In patients exposure the contrast media within one week before cisplatin administration, the risk of CIN was observed higher than in patients not exposure to the contrast. No additional risk factor of CIN was found in this retrospective observational study." @default.
• W2997863586 created "2020-01-10" @default.
• W2997863586 creator A5004702237 @default.
• W2997863586 creator A5026279555 @default.
• W2997863586 creator A5033820961 @default.
• W2997863586 creator A5034419246 @default.
• W2997863586 creator A5046987799 @default.
• W2997863586 creator A5052112651 @default.
• W2997863586 creator A5052748672 @default.
• W2997863586 creator A5054275694 @default.
• W2997863586 creator A5064384585 @default.
• W2997863586 date "2012-05-20" @default.
• W2997863586 modified "2023-09-23" @default.
• W2997863586 title "Administration of contrast media just before the cisplatin-based chemotherapy increases the cisplatin-induced nephrotoxicity." @default.
• W2997863586 doi "https://doi.org/10.1200/jco.2012.30.15_suppl.e13031" @default.
• W2997863586 hasPublicationYear "2012" @default.
• W2997863586 type Work @default.
• W2997863586 sameAs 2997863586 @default.
• W2997863586 citedByCount "0" @default.
• W2997863586 crossrefType "journal-article" @default.
• W2997863586 hasAuthorship W2997863586A5004702237 @default.
• W2997863586 hasAuthorship W2997863586A5026279555 @default.
• W2997863586 hasAuthorship W2997863586A5033820961 @default.
• W2997863586 hasAuthorship W2997863586A5034419246 @default.
• W2997863586 hasAuthorship W2997863586A5046987799 @default.
• W2997863586 hasAuthorship W2997863586A5052112651 @default.
• W2997863586 hasAuthorship W2997863586A5052748672 @default.
• W2997863586 hasAuthorship W2997863586A5054275694 @default.
• W2997863586 hasAuthorship W2997863586A5064384585 @default.
• W2997863586 hasConcept C126189478 @default.
• W2997863586 hasConcept C126322002 @default.
• W2997863586 hasConcept C143998085 @default.
• W2997863586 hasConcept C2776694085 @default.
• W2997863586 hasConcept C2778239845 @default.
• W2997863586 hasConcept C29730261 @default.
• W2997863586 hasConcept C71924100 @default.
• W2997863586 hasConcept C98274493 @default.
• W2997863586 hasConceptScore W2997863586C126189478 @default.
• W2997863586 hasConceptScore W2997863586C126322002 @default.
• W2997863586 hasConceptScore W2997863586C143998085 @default.
• W2997863586 hasConceptScore W2997863586C2776694085 @default.
• W2997863586 hasConceptScore W2997863586C2778239845 @default.
• W2997863586 hasConceptScore W2997863586C29730261 @default.
• W2997863586 hasConceptScore W2997863586C71924100 @default.
• W2997863586 hasConceptScore W2997863586C98274493 @default.
• W2997863586 hasLocation W29978635861 @default.
• W2997863586 hasOpenAccess W2997863586 @default.
• W2997863586 hasPrimaryLocation W29978635861 @default.
• W2997863586 hasRelatedWork W1963555838 @default.
• W2997863586 hasRelatedWork W1989447858 @default.
• W2997863586 hasRelatedWork W1998226689 @default.
• W2997863586 hasRelatedWork W2009989062 @default.
• W2997863586 hasRelatedWork W2035186429 @default.
• W2997863586 hasRelatedWork W2059068055 @default.
• W2997863586 hasRelatedWork W2093544927 @default.
• W2997863586 hasRelatedWork W2108730543 @default.
• W2997863586 hasRelatedWork W2141521302 @default.
• W2997863586 hasRelatedWork W2383166569 @default.
• W2997863586 hasRelatedWork W2416780186 @default.
• W2997863586 hasRelatedWork W2605828460 @default.
• W2997863586 hasRelatedWork W2800852263 @default.
• W2997863586 hasRelatedWork W2955021271 @default.
• W2997863586 hasRelatedWork W3029149988 @default.
• W2997863586 hasRelatedWork W3120974432 @default.
• W2997863586 hasRelatedWork W3134902300 @default.
• W2997863586 hasRelatedWork W3158698733 @default.
• W2997863586 hasRelatedWork W73627667 @default.
• W2997863586 hasRelatedWork W93875272 @default.
• W2997863586 isParatext "false" @default.
• W2997863586 isRetracted "false" @default.
• W2997863586 magId "2997863586" @default.
• W2997863586 workType "article" @default.